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Comparison of different cardiovascular
magnetic resonance sequences for native
myocardial T1 mapping at 3T
Tiago Teixeira1,2*, Tarik Hafyane1, Nikola Stikov1,3, Cansu Akdeniz1, Andreas Greiser4 and Matthias G. Friedrich1,5
Abstract
Background: T1 mapping based on cardiovascular magnetic resonance (CMR) is a novel approach using the magnetic
relaxation T1 time as a quantitative marker for myocardial tissue composition. Various T1 mapping sequences are being
used, with different strengths and weaknesses. Data comparing different sequences head to head however are sparse.
Methods: We compared three T1 mapping sequences, ShMOLLI, MOLLI and SASHA in phantoms and in a
mid-ventricular slice of 40 healthy individuals (mean age 59 ± 7 years, 45 % male) with low (68 %) or moderate
cardiovascular risk. We calculated global and segmental T1 in vivo through exponential curve fitting and subsequent
parametric mapping. We also analyzed image quality and inter-observer reproducibility.
Results: There was no association of T1 with cardiovascular risk groups. T1 however differed significantly depending
on the sequence, with SASHA providing consistently higher mean values than ShMOLLI and MOLLI (1487 ± 36 ms vs.
1174 ± 37 ms and 1199 ± 28 ms, respectively; p < 0.001). This difference between sequences was much smaller in
phantom measurements. In patients, segmental values were lower in the anterior wall for all sequences. Image quality,
in general good for the steady-state-free-precession readouts in all sequences, was lower for SASHA parametric maps.
On multivariate regression analysis, a longer T1 measured by MOLLI was correlated with lower ejection fraction and
female gender. Inter-observer variability as assessed by intra-class correlation coefficients was excellent for all
sequences (ShMOLLI: 0.995; MOLLI: 0.991; SASHA: 0.961; all p < 0.001).
Conclusion: In a cross-sectional population with low to moderate cardiovascular risk, we observed a variation in T1
mapping results between inversion-recovery vs. saturation-recovery sequences in vivo, which were less evident in
phantom images, despite a small interobserver variability. Thus, physiological factors, most likely related to B1
inhomogeneities, and tissue-specific properties, like magnetization transfer, that impact T1 values in vivo, render
phantom validation insufficient, and have to be further investigated for a better understanding of the clinical
utility of different T1 mapping approaches.
Trial registration: “Canadian Alliance For Healthy Hearts and Minds” – ClinicalTrials.gov NCT02220582; registered
August 18, 2014.
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Background
T1 mapping, which refers to the pixelwise quantification
of the myocardial longitudinal relaxation time T1, is a rap-
idly emerging Cardiovascular Magnetic Resonance (CMR)
technique which has demonstrated a strong potential to
characterize abnormalities related to acute and chronic
myocardial injury [20]. Global T1 measurements can be
determined either by analyzing the intensity of a group of
pixels in a parametric T1 map, but also by deriving an
exponential T1 recovery curve based on ROIs from a
number of steady-state free precession (SSFP) images with
varied inversion times. [20]. Among the applied
sequences, inversion-recovery techniques based on Look-
Locker protocols (MOLLI, ShMOLLI) and saturation-
recovery sequences (SASHA) have been used most
frequently. Yet, more than 10 years after the first clinical
study on myocardial T1 mapping [18, 19] and numerous
reports on its utility for identifying different processes
such as edema [8, 10] and diffuse fibrosis [2], the specific
clinical utility of currently used protocols is not well
understood. Specifically, there is a paucity of comparative
data between these approaches beyond phantom experi-
ments [13], especially in a suitable reference middle-aged
population with low to moderate cardiovascular risk.
The aim of our study was to compare the ability of
three major T1 mapping techniques, ShMOLLI, MOLLI
5(3)3 and SASHA, to determine the native relaxation T1
times in phantoms and in subjects from a population-
wide cohort.
Methods
Phantom experiments
We performed experiments using two different Agar-
ose and NaCl gel phantoms, here referred to as
“HCMR” [16] (from the HCMR study: ClinicalTrials.-
gov NCT01915615) and “T1MES” [3], both composed
of 3 × 3 array of plastic tubes filled with T1/T2 mix-
tures (T1 ~ 100–3000 ms and T2 ~ 50–200 ms), the
tubes’ base resting on a resin layer. The two phantoms
were scanned in the same MRI machine using identical
imaging parameters as for the in-vivo T1 mapping
experiments (see CMR acquisition parameters section
below). T2 mapping was also performed using a T2-
prepared TrueFISP sequence [12] at the same slice
position as for the T1 mapping. A simulated heart rate
of 60 bpm was used.
Reference T1 relaxation times were calculated off-
line based on five images collected using slice-
selective IR with a turbo spin echo readout: Inversion
times (TI) = 33, 100, 900, 2700, and 5000 ms, respect-
ively; Temporal resolution (TR)/Echo time (TE) =
10s/12ms; Turbo factor = 7; 80 phase encoding steps
with total image acquisition time of 372 s. Regions of
interest were placed in each tube using an automated
method and reference T1s were fitted per pixel and
the mean T1 determined [1].
Study population
Participants of the “Canadian Alliance For Healthy Hearts
and Minds” prospective cohort (ClinicalTrials.gov
NCT02220582) were offered to participate. The “Alliance”
cohort is a joint Canadian effort to understand underlying
risk factors for cardiac, vascular and cognitive dysfunction
and will recruit more than 8,000 subjects from a multi-
ethnic general population. Exclusion criteria for Alliance
cohort are the generally accepted contraindications to MR
(implantable devices, cochlear implants, cerebral
aneurysm clips, severe claustrophobia), and renal dysfunc-
tion (current eGFR < 60 mL/min/1.73 m2).
Participants were recruited trough the Montreal Heart
Institute (MHI) Biobank, consisting of patients of the
MHI and their relatives. Between October 2014 and
March 2015, 65 asymptomatic participants were
recruited. After exclusion of participants with myocar-
dial infarction (n = 6), valvular dysfunction (n = 6) or an
implanted MR-incompatible device (n = 1), the presence
of more than 3 risk factors (n = 5) or end-organ disease
(n = 7), our study population consisted of 40 participants
(mean age 58.7 ± 7.0; 45 % male).
History taking and assessment specifically included
hypertension, diabetes mellitus, dyslipidemia, overweight
(BMI > 30 kg/m2), smoking status, family history of pre-
mature cardiovascular events, and sedentary lifestyle.
We used a qualitative cardiovascular risk score approach
[17] to classify participants from “no added risk” (no risk
factors) to “moderate added risk” (i.e. arterial hyperten-
sion with two or less cardiovascular risk factors, exclud-
ing diabetes mellitus; or diabetes mellitus, but without
other risk factors).
CMR acquisition parameters
All CMR scans were performed using a 3 Tesla clinical
MRI system (Magnetom Skyra™, Siemens Healthcare,
Erlangen, Germany), software platform Skyra VD13. We
applied cine CMR sequences (steady state free preces-
sion) for ventricular function, mass and morphology
[11], consistent with the standard scan protocol of the
Alliance cohort, including three long axis views and a
stack of short axis slices covering the entire heart, using
the following parameters: Field of view (FOV) typically
320–350 mm; matrix 208x168; TE 1.43 ms; TR
39.12 ms; echo spacing 2.8 ms; slice thickness 8 mm
with 2 mm gap; flip angle (FA) 49°; bandwidth (BW)
960Hz; 25 reconstructed phases per heartbeat.
We applied prototype sequences for T1 mapping
(Siemens ASP #780B), in random order, all performed
using 18-channel phased array body matrix coils (an-
terior and posterior). Patient-specific shimming and
Teixeira et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:65 Page 2 of 12
center frequency adjustments were performed before T1
mapping to generate images free from off-resonance arti-
facts. Regular parameters used were:
 ShMOLLI 5(1)1(1)1[23]: 7 SSFP readouts in 9
heartbeats; slice thickness 8 mm; FA 35°; TE
1.07 ms; TR 2.58 ms; sampling rate 100 %;
acquisition matrix 192 × 144; FOV ~ 320–350 mm;
84 segments; phase partial Fourier 6/8; BW 900Hz;
minimal TI 100 ms; TI increment, 80 ms; parallel
imaging (GeneRalized Auto-calibrating Partially
Parallel Acquisition, GRAPPA) with an acceleration
factor of 2; imaging window 167 ms.
 MOLLI 5(3)3[14]: 8 SSFP readouts in 11 heartbeats;
slice thickness 8 mm; FA 35°; TE 1.07; TR 2.58 ms;
matrix 192×144; FOV ~ 320–350 mm; 72 segments;
minimum TI 100 ms; TI increment 80 ms; GRAPPA
acceleration factor 2; imaging window 136 ms.
 SASHA [5]: 11 SSFP readouts in 11 heartbeats; slice
thickness 8 mm; composite saturation with six RF
pulses, FA 70° (optimized BIR4-90); TE 1.07 ms; TR
2.58 ms; matrix 192 × 144; FOV ~ 320–350 mm; 84
segments; saturation times spaced uniformly over
the RR interval with minimum saturation recovery
time of 100 ms; phase partial Fourier 6/8; BW
900 Hz; GRAPPA acceleration factor 2, imaging
window 167 ms.
All sequences provided raw SSFP readouts, parametric
maps and error maps, and for MOLLI and SASHA
motion-corrected SSFP readouts (Siemens in-built).
T1 analysis
The analysis was performed in the CMR Core Lab at the
Montreal Heart Institute, using certified postprocessing
software (cvi42, Circle Cardiovascular imaging, Calgary,
Canada), software version 5.1.2 (303), and according to
published societal recommendations [11, 28].
Quantitative analysis
There are two ways to perform T1 measurements: 1)
choose myocardial regions of interest (ROI) in SSFP read-
outs, either raw or after motion-correction (MOCO), and
evaluate them in a devoted software that determines the
T1 value by using exponential curve fitting, accounting
for specific algorithms of each sequence used, which we
will refer as ROI-based analysis; 2) use parametric maps,
which already contain pixel-wise information on T1 values
(in our case we could generate cvi42-derived maps along
with the ones generated inline by the scanner), which are
referred to as pixel-map based analysis. T1 quantification
was performed first by manually delineating the endocar-
dial and epicardial contours of the LV myocardium, on
the parametric map provided inline by the scanner, using
a color scale of 0 to 2000 ms. Contours were drawn ensur-
ing a ROI within the myocardium and excluding neigh-
boring pixels from blood or epicardial fat (pixel-map
based analysis). These contours were then copied and
pasted to the first motion-corrected SSFP image (when
available), and forwarded to the remaining SSFP readouts
(ROI-based analysis). The contours were adjusted for min-
imal respiratory motion induced position changes. T1 was
automatically determined by the software, from exponen-
tially fitted curves, after selection of sequence-specific
algorithms (conditional fitting for ShMOLLI, Look-Locker
correction for MOLLI and 2-parameter fitting for
SASHA), and accepted, if R2 of the calculated T1 curve
function was equal to or higher than 0.995.
We further generated parametric maps by the software
(automatic in under 30 s), using the motion-corrected
Siemens readouts, and used them to estimate global and
segmental [4] T1 values, using the same contours as for
the inline maps (pixel-map based analysis). Segments
affected by artifacts, particularly susceptibility artifacts,
were excluded from the analysis.
For MOLLI a correction factor of 1.03 was applied off-
line to the values obtained both on the ROI-based analysis
and the cvi pixel-map based analysis, as recommended by
Siemens for any third-party analysis software.
A second reader (CA) repeated the analysis in 10
healthy participants for assessment of inter-observer
variability.
Qualitative analysis
For the three T1 mapping sequences, SSFP images and
T1 maps were evaluated qualitatively in relation to
image quality, using a three point scale: 1 – poor image
quality (motion-correction artifacts, susceptibility arti-
facts involving all the myocardium or motion artifacts
preventing border visualization on SSFP images; signifi-
cant color heterogeneity or susceptibility artifacts involv-
ing all the myocardium on T1 maps); 2 – average image
quality (small susceptibility artifacts on SSFP images or
T1 maps); 3 – good image quality (absence of artifacts
on SSFP images; signal homogeneity on T1 maps).
Statistical analysis
Continuous variables are presented as mean ± standard
deviation (SD). Comparison of normally distributed vari-
ables was performed by Student’s t-test, one-way analysis
of variance (ANOVA) and repeated measures ANOVA
(both with Bonferroni’s post-hoc test), as appropriate.
Categorical variables were expressed as percentage and
compared using the X2 test, using a linear approach and
Kendall’s tau for ordinal variables. Pearson’s correlation
coefficient analysis was used to determine the stronger
association between T1 measurements estimated by the
ROI-based and pixel-map based approaches for in-vivo
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experiments, and for the correlation between sequences
and reference T1 times in phantom experiments. Univar-
iate predictors of T1 times were assessed with a multiple
linear regression model. Fixed and proportional biases
with 95 % limits of agreement were further assessed
using Bland-Altman analysis. Inter-observer variability
was assessed using intra-class correlation coefficients
(ICC). All statistical analysis was performed using SPSS
version 21 (SPSS, Inc., Chicago, IL). A two-sided p < 0.05
was considered statistically significant.
Results
Phantom experiments
In the in-vitro experiments, all sequences showed excellent
correlation with the reference T1 times, as shown in Fig. 1
(for “HCMR” phantom: ShMOLLI y = 1.02x – 99.75,
SASHA y = 0.99x – 5.41, MOLLI y = 0.98x – 29.26; for
T1MES phantom: SASHA y = 0.99x – 8.25, MOLLI y =
0.95x – 6.62, ShMOLLI y = 0.92x – 4.51). The inversion-
recovery techniques, particularly ShMOLLI, showed slight
underestimation of T1 (~ 150 ms) (Fig. 2), while SASHA
was the sequence least affected by increasing T2 values,
presenting the smallest slope in the error curve, fact more
evident when using T1MES, a more recent phantom that
better accounts for this factor (T1MES curve has three dif-
ferent T2 values, ranging from 50 to 55 ms, closer to in-
vivo reality when compared to HCMR’s curve, with only
two, 57 and 75 ms). We further calculated the absolute
error of the estimated T1 by the three sequences, against
the gold standard inversion recovery spin-echo, for T1MES
(Fig. 3). We verified that SASHA shows the best agreement
(−23.73 ± 8.38), and both MOLLI and ShMOLLI show
greater underestimation (respectively, −89.47 ± 35.93 and
−139.23 ± 38.27), for the different T1 and T2 values.
SASHA showed the lowest precision, with higher
standard deviation between measurements as compared
to both ShMOLLI and MOLLI, p < 0.05 (Fig. 4).
Participant studies
Recorded conditions at inclusion of the subjects in the
database were: absent (62.5 %), negative ischemic evalu-
ation (22.5 %), rhythm disorder (10 %) or other (5 %).
Demographic characteristics, clinical and CMR results
are presented in Table 1. We analyzed the different
added-risk groups: normal volunteers (without any risk
factors); low added-risk group (presence of 1–2 risk fac-
tors, without known hypertension); and hypertensives
(with or without at most two other risk factors on top of
hypertension). The hypertensive group, mostly consti-
tuted of moderate added-risk patients, had higher preva-
lence of dyslipidemia (p < 0.01), while the low added-risk
group had a higher prevalence of a family history of pre-
mature CV disease (p < 0.01). The latter had also higher
prevalence of risk factors (p < 0.001), but in 78 % of the
cases only one risk factor was present. No other differ-
ences were found between groups, namely in routine
MR parameters or T1 values within sequences.
Comparison of T1 measurements from different
sequences in vivo
Resulting T1 values differed between sequences. Using a
ROI-based analysis, SASHA resulted in values almost
300 ms higher than those acquired by the other two
sequences, ShMOLLI and MOLLI (ShMOLLI 1173.6 ±
37.0; MOLLI 1199.2 ± 27.5; SASHA: 1486.8 ± 36.0; p <
0.001). The post-hoc analysis, including only 32 partici-
pants due to the exclusion of 8 ShMOLLI curves with a
R2 < 0.995, shows significant differences between all
sequences (Table 2). Heart rates did not differ between
sequences.
Comparison of T1 analysis methods
We further calculated the T1 times using both sets of
parametric maps (pixel-map based analysis), the ones
originated inline from the scanner and the ones derived
Fig. 1 Native T1 for all sequences with different phantoms. The correlation of the measured T1 times and the predetermined T1 times was
excellent ex-vivo, with an R2 = 0.99 on all sequences, for both phantoms
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from the analysis software. Using the ROI-based analysis
as standard, both sets of maps perform fairly equally, par-
ticularly for ShMOLLI (r: 0.90 vs 0.93; dif −11.23 vs 9.75)
and MOLLI (r: 0.95 vs 0.97; dif 4.9 vs −3.4), but with a
stronger correlation with cvi42 parametric maps when
using SASHA (r: 0.74 vs 0.97; dif −6.51 vs −2.90) (Fig. 5).
Segmental analysis was conducted in the parametric
maps, (as generated by cvi42), the results shown in Fig. 6.
The anterior segment had consistently lower T1 times in
all the sequences, with higher values in the inferior/
infero-lateral segments (p < 0.01). Regarding the segmen-
tal analysis, we excluded 0.7 % of the segments of
SASHA and MOLLI sequences, due to susceptibility
artifacts. For ShMOLLI, 17.7 % of the segments were
excluded, but only 1 % of these were due to susceptibil-
ity artifacts (not statistically different from other se-
quences); the remaining 16.7 % corresponded to the
aforementioned 8 ShMOLLI cases without acceptable fit-
ting curves, related to heart rate mis-registration (a tech-
nical problem in our scanner).
Image quality
Fig. 7 shows an overview of the observed image quality.
All the SSFP readouts had acceptable or good quality,
with susceptibility artifacts progressively less identified
in MOLLI, SASHA and ShMOLLI images (p < 0.001).
Parametric maps had a lower quality with the SASHA
approach when compared with ShMOLLI (p < 0.01) and
Fig. 2 Impact of T2 on T1 measurements. MOLLI and ShMOLLI underestimated native T1 due to T2 effects, more prominently seen in shorter T2
times. SASHA was least affected by T2, as more obvious in images from the T1MES phantom (right panel)
Fig. 3 Error curves for the three sequences on T1MES. Absolute error in MOLLI, SHMOLLI and SASHA T1 values compared to gold standard
inversion-recovery spin-echo (IR-SE) in native tissue-like phantom samples (T1s 1000–1500 ms, T2 50–55 ms), Post contrast tissue-like phantom
samples (T1s 300–600 ms, T2 60–85 ms) and blood pool like phantom (T1 1880 ms, T2 160 ms). Continuous lines represent averages
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MOLLI (p < 0.05), showing a significant percentage of
heterogeneous maps, seldom present in other sequences’
maps. Representative examples of the SSFP readouts and
parametric maps are shown in Fig. 8.
Determinants of T1 values
A multivariate analysis including age, gender, ejection
fraction and presence of hypertension and obesity,
showed significant relationship with the model (r = 0.54)
in MOLLI only, with a negative correlation with ejection
fraction (Fig. 9) and a positive correlation with female
gender (both p < 0.05).
Inter-reader variability
The intraclass correlation coefficients were excellent be-
tween both readers for the three sequences, when T1
was evaluated using the ROI-based analysis (ShMOLLI:
0.995; MOLLI: 0.991; SASHA: 0.961; all p < 0.001). The
coefficients for T1 evaluation using the parametric maps,
were still excellent overall, albeit lower (0.888) in the an-
terolateral segment of MOLLI images and the anterior
(0.841) and infero-septal (0.886) segments in the SASHA
images.
Fig. 4 Comparison of the observed precision of sequences on phantom
experiments. SASHA showed a higher standard deviation between
measurements when compared to both ShMOLLI and MOLLI (p < 0.05)
Table 1 Demographic characteristics and CMR results in participants
Variables Healthy Low added risk Moderate added risk Sig
(n = 9) (n = 18) (n = 13) (p value)
Age (years) 58.4 ± 11.1 59.2 ± 5.4 58.2 ± 5.7 0.93
Male gender (%) 33.3 44.4 53.8 0.64
Diabetes M. (%) 0 0 15.4 0.11
Dyslipidemia (%) 0 11.1 61.5 < .01
Obesity (%) 0 27.8 23.1 0.22
Current smoker (%) 0 11.1 0 0.57
Sedentary (%) 0 0 0 –
FH CVD (%) 0 72.2 38.5 < .01
Hypertension (%) 0 0 100 < .001
SBP (mmHg) 129.3 ± 21.4 134.3 ± 16.8 136.9 ± 20.2 0.66
DBP (mmHg) 74.8 ± 9.1 81.8 ± 9.2 79.3 ± 15.8 0.35
RF (0/1/2/3) 9/0/0/0 0/14/4/0 0/2/4/7 < .001
LVEDV (ml) 123.8 ± 26.4 121.9 ± 35.1 129.5 ± 29.6 0.80
LVESV (ml) 45.8 ± 13.4 39.3 ± 16.1 41.1 ± 12.8 0.55
EF (%) 63.1 ± 6.0 68.3 ± 6.2 68.4 ± 5.1 0.07
LVM (g) 99.9 ± 23.3 112.6 ± 31.3 127.8 ± 35.1 0.11
Native T1
ShMOLLI (ms) 1177.7 ± 28.6 1166.8 ± 24.3 1178.7 ± 51.7 0.70
MOLLI 5(3)3 (ms) 1207.9 ± 18.2 1197.0 ± 20.9 1206.8 ± 39.0 0.51
SASHA (ms) 1486.0 ± 24.1 1479.8 ± 29.6 1496.9 ± 48.9 0.44
FH family history, CVD cardiovascular disease, SBP systolic blood pressure, DBP diastolic blood pressure, RF risk factors, LVEDV left-ventricular end-diastolic volume,
LVESV left-ventricular end-systolic volume, EF ejection fraction, LVM left-ventricular mass, Sig significance
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Discussion
Our results indicate that, despite excellent inter-observer
variability and good in-vitro correlation of various T1
mapping sequences, results vary in vivo between
saturation-recovery sequences and inversion-recovery
approaches. Furthermore, saturation-recovery sequences
may provide less homogenous parametric maps (Fig. 5).
Native T1 of tissue in vivo can be estimated from signal
intensities in images with varying inversion or saturation
times through calculating an exponential T1 recovery
curve [20]. The original Look-Locker technique was modi-
fied to a single-breath-hold technique with steady-state
free precession (SSFP) readouts, known as Modified
Look-Locker Inversion recovery (MOLLI) sequences [19].
This approach was further modified by Piechnik et al. with
a Shortened adaptation with conditional curve fitting/
ShMOLLI [23], allowing shorter breath-holds and less
heart rate susceptibility. Modified MOLLI versions with
fewer off-resonance artifacts were then necessary [14].
However, all these techniques still require a correction fac-
tor to account for underestimation of T1 due to
magnetization attenuation [9]. Furthermore, T2 affects the
results and, while T1 and T2 changes typically are corre-
lated, the T1 acquired by MOLLI techniques may not rep-
resent a “true” T1. Chow et al. added a protocol based on
images with varying saturation times, called SAturation
recovery Single-sHot Acquisition (SASHA) sequence [5],
which showed good accuracy [13]. No correction factor is
necessary and there is no significant impact of tissue T2,
but the curve fitting assumes a fully saturated tissue envir-
onment, which may not be present. Hybrid sequences are
also available, that integrate some of the advantages of sat-
uration and inversion-recovery [31].
All these techniques have different issues and while a
consensus group is working on standardizing termin-
ology and techniques [20], problems remain regarding
the standardized use of techniques and the lack of ac-
cepted reference values. While some diseases such as
cardiac amyloidosis or acute myocardial infarction show
a strong increase in native T1, more subtle differences
are obtained in conditions with less myocardial damage
such as valvular heart disease with LV hypertrophy [27].
Thus, even small differences between calculated results
limit the clinical utility of T1 mapping, if sequences and
evaluation procedures are not standardized.
Reported reference values for the different techniques
were acquired in studies with variable sample sizes and
for different field strengths [7, 24, 30]. MOLLI sequences
result in reference values (mean ± 2*SD) of 900 and
1050 ms at 1.5 T, while at 3 T myocardial T1 was found
to be between 1100 and 1250 ms [21, 22]. Our results,
obtained in a cross-sectional, middle-aged population at
a low to moderate risk, are similar. Furthermore, we did
not find a significant correlation with the cardiovascular
risk profile, which is consistent with two recent studies,
one by Dabir et al. [7], where a low-risk population had
similar T1 values as normal volunteers, and one by Sado
et al. with a reported overlap of T1 times of normal sub-
jects and patients with arterial hypertension [27].
In our study, T1 as estimated by ShMOLLI and MOLLI
was significantly lower than estimated by SASHA. While
there are no data on reference values for T1 measure-
ments based on SASHA at 3T, the observed difference is
consistent with a previous review by Kellman and Hansen
[13], who found a difference of about 200 ms between in-
version and saturation-based methods, when determined
at 1.5T. We observed a similar difference in the phantom
experiments, which was amplified on the in-vivo measure-
ments. In their review, Kellman and Hansen discuss a var-
iety of factors that may affect T1 mapping accuracy, such
as patient and tissue characteristics, protocol parameters,
scanner and sequence adjustments, and fit models. In our
sample the heart rate during SASHA acquisition was not
different from the other sequences, being low (66.5 ± 12.1)
and very close to the heart rate used in the phantom ex-
periments, where there was not a wider difference in T1
estimation between sequences. Other tissue characteristics
may further impact results relative to the phantom
models, mostly in inversion-recovery techniques, leading
to lower T1 values. In particular, magnetization transfer
(MT) may be responsible for about 15 % of the assumed
underestimation of T1 times with MOLLI, while this con-
founding effect is reduced with SASHA, a sequence that is
less dependent on T2, at least when using a 3-parameter
fit [25]. Magnetization transfer may therefore have been
one of the major contributors to the inter-sequence differ-
ences. In our case, both scanner and sequence parameters
were kept unchanged throughout all experiments. The
SASHA fitting routine assumes perfect saturation (90° flip
angle), but B1+ inhomogeneities and variations in the
transmit gain could produce deviations from 90° and re-
sult in a T1 bias. Although using different sequences, Sti-
kov et al. [29] reported similar findings in the brain,
suggesting improper B1 correction as the reason for poor
agreement between sequences in vivo (with variable flip
angles), but not in phantoms. Importantly, a variable flip
angle approach for SASHA has been reported recently as
a means of reducing systematic errors [6].
The lower precision of SASHA, i.e. a higher variability
of results, is a known disadvantage [26]. We also ob-
served a marked heterogeneity of T1 compared with the
Table 2 Comparison of mid-ventricular native T1 values as
derived from different T1 mapping sequences
Sequences ShMOLLI MOLLI 5(3)3 SASHA p value
T1 values (ms) 1173.6 ± 37.0 1200.3 ± 29.1 1492.7 ± 31.6 < 0.001
Heart rate (bpm) 65.7 ± 11.8 65.7 ± 11.8 66.5 ± 12.1 0.21
ms Milliseconds, bpm beats per minute
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Fig. 5 Bland-Altman plots of the difference between native T1 measurements using ROI-based and pixel-map based analysis, either generated by
offline analysis (left) and inline/scanner-generated analysis (right), for the three sequences. ShMOLLI’s and MOLLI’s graphs are similar, but SASHA’s
measurements show a lower dispersion when using the offline maps
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other sequences. Different curve fit algorithms or sam-
pling schemes may reduce this problem [15]. Our results
did not seem to be related to artifacts in the SSFP read-
outs. For example, even though SASHA had fewer sus-
ceptibility artifacts in the SSFP images, the resulting T1
maps were of lower quality than maps based on MOLLI.
We used a ROI-based analysis for T1 measurements
because the ROI-based approach allows for corrections
of motion-correction imperfections or problems with
cardiac phase registration. The pixel-map based ap-
proach is however a fair alternative, as shown in our
study. The maps, as main overall advantage, enable a
qualitative interpretation, priceless on clinical evaluation.
That type of interpretation is quite difficult when using
the SSFP readouts of the ROI-analysis, due to the ag-
gressive windowing needed to define the myocardium
on images with different T1s (shades of gray). We found
the qualitative interpretation to be more frequently
achieved with the inversion-recovery sequences, due to
the referred homogeneity issues we encountered with
SASHA’s maps. The maps further allow the analysis of
myocardial segments. We confirmed the findings of
other groups, with lower T1 at the anterior segments
and higher values in the inferior/infero-lateral segments
[30]. While a physiologic phenomenon cannot be com-
pletely excluded, it more likely represents an artifact.
Our study had several limitations. The sample is small
and heterogeneous, and suffered further from missing
heart rate data from the scanner. Even though we ex-
cluded those values from the analysis, the pixel-map
based analysis from the Siemens inline generated maps,
could have allowed for T1 estimation when we experi-
enced this error (average T1 on 7 out of 8 cases: 1176 ±
18 ms). Nevertheless, the impact of cardiovascular risk
on T1 has to be studied in larger samples, to confirm
the significant differences of measured T1 between se-
quences. This is a field at constant development, and
any analysis may risk to become outdated by the time of
reporting. Marked improvements have, in fact, been im-
plemented on some of these sequences, specifically a
Fig. 6 Segmental analysis of native T1 times using parametric maps. Bright yellow colors represent higher T1. T1 is consistently lower in the
anterior segments than in the inferior and infero-lateral segments (p < 0.01). Such an inhomogeneity is less evident in T1 results acquired
by SASHA
Fig. 7 Evaluation of image quality between sequences. On the left the grey steady-state free precession (SSFP) readouts, and on the right the
parametric color maps. Values are expressed as percentage. There was good overall image quality of SSFP images, with some susceptibility arti-
facts, affecting mostly MOLLI. Image quality was poorer on SASHA parametric maps, with about 2/3 showing less-than-good quality
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variable flip angle approach for SASHA that may have
led to smaller observed differences between sequences
and reduced homogeneity issues with that sequence. We
only acquired a single myocardial slice and variations
may be more or less pronounced in basal and apical
slices. Yet, the observed differences and our conclusions
on clinical utility of T1 mapping sequences remain valid.
Conclusion
While performing T1 mapping in phantoms and in a
cross-sectional population with low to moderate cardio-
vascular risk, we observed a small interobserver variabil-
ity of T1 measurements. The MOLLI sequence showed
the smallest overall variability and SASHA the best ac-
curacy. Most importantly, measured T1 varied between
Fig. 8 Example of representative SSFP images (top) and color maps (bottom) for each sequence, from left to right ShMOLLI, MOLLI and SASHA.
Notice the susceptibility artefact present in all sequences (infero-lateral wall), in the SSFP images. The scale was chosen to keep the same interval
(200 ms) in the range of each sequence (900–1100 ms for ShMOLLI and MOLLI; 1400–1600 ms for SASHA)
Fig. 9 Scatter plot showing a weak negative correlation between ejection fraction and native T1 times estimated by MOLLI. The multivariate
model included age, gender, ejection fraction and presence of hypertension and obesity
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inversion-recovery vs. saturation-recovery sequences in
vivo, much more than in phantom images. Thus, physi-
cians applying or interpreting the technique should be
aware that phantom validation does not directly trans-
late to in vivo application, because physiological factors,
most likely related to B1 inhomogeneities, the position
of the heart in the coil reception field, T2 sensitivity,
magnetization transfer effects and physiologic varia-
tions impact on T1 values (whether between different
methods like IR vs SR, or within a single method), and
have therefore to be further investigated for a better
understanding of the clinical utility of different T1
mapping approaches.
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